Effect of Fresh Gas Flow on Emergence Time
NCT05376631 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2022-08-18
Summary
The purpose of this study is to evaluate the effect of fresh gas flow on emergence time in patients undergoing transurethral resection of bladder tumor.
Conditions
Interventions
- PROCEDURE
-
Fresh gas flow of 5 L/min
A fresh gas flow of 5 L/min is used during emergence from general anesthesia.
- PROCEDURE
-
Fresh gas flow of 10 L/min
A fresh gas flow of 10 L/min is used during emergence from general anesthesia.
Sponsors & Collaborators
-
Asan Medical Center
lead OTHER
Principal Investigators
-
Young-Kug Kim, MD, PhD · Asan Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-20
- Primary Completion
- 2022-08-16
- Completion
- 2022-08-17
Countries
- South Korea
Study Locations
More Related Trials
-
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
NCT02547350 ·Status: UNKNOWN ·Phase: PHASE2
-
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
NCT02716961 ·Status: UNKNOWN ·Phase: NA
-
HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer
NCT06327932 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Clinicoepidimiological Study and Clinical Outcome in Patients With Urinary Bladder Cancer
NCT04525781 ·Status: UNKNOWN
-
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
NCT07036731 ·Status: RECRUITING ·Phase: NA
-
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
NCT03266900 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer
NCT02514408 ·Status: WITHDRAWN
-
Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients
NCT05739968 ·Status: RECRUITING ·Phase: NA
-
Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer
NCT06337305 ·Status: COMPLETED
-
Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors
NCT03238664 ·Status: WITHDRAWN ·Phase: NA
-
Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.
NCT04939194 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection
NCT00816075 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
NCT04235764 ·Status: RECRUITING
-
Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors
NCT03839472 ·Status: WITHDRAWN ·Phase: NA
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
NCT00777491 ·Status: COMPLETED ·Phase: PHASE2
-
Intravesical BCG: is the Urinary Bladder Ready to Receive it
NCT05335512 ·Status: NOT_YET_RECRUITING
-
Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma
NCT03296306 ·Status: UNKNOWN ·Phase: PHASE3
-
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
NCT06324058 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection
NCT07279792 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer
NCT00055601 ·Status: COMPLETED ·Phase: PHASE2
-
Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma
NCT04570410 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation
NCT03058757 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma
NCT04865939 ·Status: RECRUITING ·Phase: PHASE3
-
Use of Immediate Hyperthermic Intravesical Chemotherapy Following TURBT
NCT03689478 ·Status: COMPLETED ·Phase: NA
-
A Study of Postoperative Adjuvant Chemotherapy for Upper Urinary Urothelial Carcinoma With Lymphovascular Invasion
NCT04255771 ·Status: UNKNOWN ·Phase: PHASE3